Literature DB >> 28074014

RISKS AND RADIATION DOSES DUE TO RESIDENTIAL RADON IN GERMANY.

T R Beck1.   

Abstract

The population-averaged risk rate and the annual average effective dose due to residential radon in Germany were calculated. The calculations were based on an epidemiological approach taking into account the age- and gender-specific lung cancer incidence rates for the German population and the excess relative risk of 0.16 per 100 Bq·m-3 for residential radon. In addition, the risk estimates adjusted for the smoking habits were determined. The population-averaged risk rate for the whole population was estimated with 4.1·10-5 y-1 (95% confidence interval (CI) 1.4·10-5-7.6·10-5 y-1). Residential radon causes a detriment per year of 3.3·10-5 y-1 (95% CI 1.1·10-5-6.0·10-5 y-1), which corresponds to an annual average effective dose of 0.6 mSv (95% CI 0.2-1.1 mSv). Annually, ~3400 lung cancer incidences are attributed to residential radon. The results from the epidemiological approach exercised in this study are considerably lower than the effective dose, which would be obtained from the dose conversion coefficient calculated using biokinetic and dosimetric models.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28074014     DOI: 10.1093/rpd/ncw374

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  2 in total

1.  The conversion of exposures due to radon into the effective dose: the epidemiological approach.

Authors:  T R Beck
Journal:  Radiat Environ Biophys       Date:  2017-09-15       Impact factor: 1.925

2.  Survey of Radon Concentrations in the University of Granada in Southern Spain.

Authors:  Irene Calvente; María Isabel Núñez; Rachid Chahboun Karimi; Juan Villalba-Moreno
Journal:  Int J Environ Res Public Health       Date:  2021-03-11       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.